Analisis Keefektifan Biaya Pengobatan Pada Pasien Pneumonia Balita Di Instalasi Rawat Inap Rumah Sakit Paru Dr. Ario Wirawan Salatiga  Tahun 2018

Wulandari, Nita Tanti; Listyanti, Ening; Dyahariesti, Niken; Erwiyani, Agitya Resti

doi:10.35473/ijpnp.v2i2.276

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For stable criteria, the respiratory rate should be 24x/minute. To see the effectiveness of the therapy using Ceftriaxone and Cefotaxime antibiotics in hospitalized pneumonia patients at Dr. Chasbullah Abdulmajid Hospital for the period January -December 2019 in terms of the respiration rate (RR) parameter (8).…”

Section: Discussionmentioning

confidence: 99%

Cost Effectiveness Analysis Treatment of Pediatric Pneumonia Antibiotic Ceftriaxon and Cefotaxime at Dr. Chasbullah Abdulmadjid Hospital

Laelasari,

Shoaliha,

H Wada

et al. 2023

MJMHS

View full text Add to dashboard Cite

Introduction: Pneumonia is inflammation in the lung parenchyma. Inflammation occurs due to infection by various organisms like bacteria, viruses, and others. This infection eventually causes the emergence of several signs and symptoms. Ceftriaxone and cefotaxime are antibiotics that are commonly and effectively used in the treatment of pneumonia. Methods: The purpose of this study is to determine the total cost of pneumonia treatment provided during hospitalization at RSUD Bekasi City. This research uses the method descriptive research with data retrieval retrospectively. The sample in this research totaled 68 patients, 34 patients used ceftriaxone antibiotics and 34 patients used cefotaxime antibiotics. Results: Cefotaxime antibiotic therapy is a more cost-effective therapy compared to Ceftriaxone. This study found the effectiveness of Ceftriaxone 88% and Cefotaxime 70% but did not reach 100% effectiveness due to the large number of patients whose length of stay (LOS) and respiration rate (RR) did not reach the target. The result showed that the average cost of treating patients with Ceftriaxone was Idr 2,171,651 and the average cost of treating patients with Cefotaxime was Idr 2,467,422. Conclusion: Ceftriaxone antibiotic therapy is a more cost-effective therapy compared to Cefotaxime which can be, seen from the ACER Ceftriaxone value of IRp. 24,677 and ICER value of Rp. -16,431.651 and the average cost of treating patients using Cefotaxime was Idr 2,467,422.

show abstract

Section: Discussionmentioning

confidence: 99%

Cost Effectiveness Analysis Treatment of Pediatric Pneumonia Antibiotic Ceftriaxon and Cefotaxime at Dr. Chasbullah Abdulmadjid Hospital

Laelasari,

Shoaliha,

H Wada

et al. 2023

MJMHS

View full text Add to dashboard Cite

show abstract

“…Selanjutnya dilakukan analisis efektivitas pengobatan dan dilakukan perhitungan persentase analisis ACER dan ICER (Andayani, 2013). Pengobatan dapat dikatakan cost-effective apabila biaya yang dikeluarkan lebih rendah namun memperoleh efektivitas yang lebih tinggi, sehingga dapat dinyatakan pengobatan tersebut adalah pilihan yang tepat (Wulandari et al, 2019). Perolehan dari CEA bisa ditarik kesimpulan melalui ICER dengan rumus berikut:…”

Section: Analisis Dataunclassified

Analisis Efektivitas Biaya Pengobatan Golongan Statin dalam Manajemen Penyakit Jantung Koroner Di RSUD Kota Madiun 2021/2022

Agustin,

Dewi,

Hanifah

2023

jmpi

View full text Add to dashboard Cite

Penyakit Jantung Koroner (PJK) menjadi salah satu prevalen dengan angka yang cukup tinggi di Indonesia. Pengobatan utama yang digunakan di RSUD Kota Madiun adalah golongan HMG-CoA Reduktase Inhibitor atau Statin, yaitu atorvastatin dan simvastatin. Penggunaan obat jangka panjang, biaya perawatan rumah sakit, frekuensi kunjungan ke dokter dan biaya pengobatan PJK menjadi beban yang signifikan. Tujuan dari studi ini adalah mengetahui cost effective antidislipidemia golongan statin pada penyakit jantung koroner. Pendekatan metode yang digunakan adalah deskriptif non-interventional, yaitu dengan mengumpulkan data secara retrospektif dari rekam medik dan billing pasien. Subyek penelitian sejumlah 64 pasien PJK yang menerima terapi simvastatin dan atorvastatin. Efektivitas pengobatan diukur berdasarkan jumlah pasien yang mencapai target penurunan LDL sebesar 18 – 55% dan peningkatan HDL 5-15%, sementara biaya yang diukur adalah biaya medis langsung yang diperoleh dari data billing selama pasien dirawat dalam satu periode rawatan. Pendekatan farmakoekonomi yang digunakan adalah Cost Effectiveness Analysis dengan menghitung nilai ACER, ICER dan analisis sensitivitas. Hasil penelitian menunjukkan rata-rata biaya total atorvastatin dan simvastatin sebesar Rp. 7.874.384 dan Rp. 6.828.385 dengan persentase efektivitas sebesar 94,28% dan 79,31%. Atorvastatin lebih cost effective dengan nilai ACER yang lebih rendah yaitu Rp. 8.352.125, sementara simvastatin sebesar Rp.8.609.740. Sehingga dapat disimpulkan bahwa antidislipidemia yang paling cost-effective adalah atorvastatin dan untuk menambah 1 efektifitas diperlukan biaya sebesar Rp. 6.987.241,15.

show abstract

The Relationship Between Mother's Behavior in Seeking Treatment With the Recurrence Rate of Pneumonia Among Children Under Five

Supiani¹,

Mufdlilah²,

Ismail

2021

wmm

View full text Add to dashboard Cite

Introduction: Pneumonia is a global problem with a significant cause of death for more than 2 million children under five every year. Mothers’ behavior in seeking treatment is one of the main factors of delay in getting proper treatment by increasing the risk of recurrence pneumonia among children under five. This study aimed to investigate the relationship between the mother's behavior in seeking treatment with the recurrence rate of pneumonia among children under five. Method: This research method was an observational analytic study with the cross-sectional approach. The number of samples in this study was 47 mothers with toddlers pneumonia. The sampling technique was using purposive sampling and data analysis used Chi-square and multiple logistic regression. Result: The study found, there was a relationship between the mothers’ behavior in seeking treatment with the recurrence rate of pneumonia among children under five (PR = 12,000; CI95%=2,275-63,285; p = 0.003). One of confounding variables namely the cost of treatment had relationship with the recurrence rate of pneumonia. Whereas the variables of mother's knowledge, access to services, and distance of residence are not related to the recurrence rate of pneumonia in infants. The results of multiple logistic regression analysis found that mothers’ behavior in seeking of the treatment, treatment cost, and distance of residence affect 51.2% of the recurrence rate of pneumonia among children under five in Yogyakarta. Conclusion: The mothers’ behavior in seeking treatment, the cost of treatment, and distance of residence affect the recurrence rate of pneumonia among children under five.

show abstract

Analisis Keefektifan Biaya Pengobatan Pada Pasien Pneumonia Balita Di Instalasi Rawat Inap Rumah Sakit Paru Dr. Ario Wirawan Salatiga Tahun 2018

Cited by 3 publications

References 0 publications

Cost Effectiveness Analysis Treatment of Pediatric Pneumonia Antibiotic Ceftriaxon and Cefotaxime at Dr. Chasbullah Abdulmadjid Hospital

Cost Effectiveness Analysis Treatment of Pediatric Pneumonia Antibiotic Ceftriaxon and Cefotaxime at Dr. Chasbullah Abdulmadjid Hospital

Analisis Efektivitas Biaya Pengobatan Golongan Statin dalam Manajemen Penyakit Jantung Koroner Di RSUD Kota Madiun 2021/2022

The Relationship Between Mother's Behavior in Seeking Treatment With the Recurrence Rate of Pneumonia Among Children Under Five

Contact Info

Product

Resources

About